Drug intelligence / Profile preview

ibuprofen arginine

Development stage
Approved
Modality
Small Molecules
Administration
Oral
01

Overview

Ibuprofen arginine is a salt form of the non-steroidal anti-inflammatory drug (NSAID) ibuprofen, combined with the amino acid L-arginine. This formulation is designed to enhance the solubility and absorption of ibuprofen, resulting in faster onset of action compared to standard ibuprofen preparations[5][8]. Ibuprofen acts as a non-selective inhibitor of cyclooxygenase enzymes COX‑1 and COX‑2, thereby reducing prostaglandin synthesis responsible for pain, inflammation, and fever[6][8]. The addition of L‑arginine not only improves pharmacokinetics but may also contribute beneficial effects through nitric oxide generation, which can further modulate inflammation[4]. Ibuprofen arginine is primarily indicated for rapid relief of mild to moderate pain associated with headache, toothache, musculoskeletal disorders, menstrual cramps, minor arthritis pain, and fever[1][5].

Brand names
FASPIC
Other names
(S)-2-Amino-5-guanidinopentanoic acid compound with 2-(4-isobutylphenyl)propanoic acid(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid;2-[4-(2-methylpropyl)phenyl]propanoic acid
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ibuprofen arginine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen arginine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call